In The News
Lawmakers have signed a bipartisan letter calling on the Department of Defense to intervene after coronavirus delays caused a major backlog of requests from veterans seeking essential service records.
The chief executive of Emergent BioSolutions, whose Baltimore plant ruined millions of coronavirus vaccine doses, disclosed for the first time on Wednesday that more than 100 million doses of Johnson & Johnson’s vaccine are now on hold as regulators check them for possible contaminati
As Emergent BioSolution's Baltimore factory was throwing away unfinished COVID-19 vaccine doses and struggling to pass muster with the Food and Drug Administration, the company awarded at least $3 million in bonuses to a handful of executives, according to documents released by a congressional subcommittee Wednesday.
Leaders of the House Science, Space and Technology Committee are requesting a briefing with the Department of Energy (DOE) on the ransomware attack that forced the Colonial Pipeline to shut down operations for nearly a week.
In the face of a sprawling congressional inquiry and sustained scrutiny over its handling of a contract to help develop coronavirus vaccines, an executive of the beleaguered biotech firm Emergent BioSolutions told lawmakers on Wednesday that he hopes to resume vaccine production "in the coming days," pending FDA sign off.
Johnson & Johnson documented serious contamination risks at a troubled Baltimore biodefense plant in June 2020, seven months before a contamination incident ruined 15 million doses of coronavirus vaccine and derailed Johnson & Johnson’s domestic vaccine production, according to documents di
On Tuesday, May 11, Rep Carolyn B. Maloney (D-N.Y.), with Congressional Maternity Care Caucus co-chairs Reps.
Three House Democrats called on the Federal Trade Commission (FTC) to investigate drugmaker AbbVie for its pricing of Humira, the best-selling drug in the U.S. and internationally.
Colonial Pipeline announced Tuesday that its internal servers were experiencing “intermittent disruptions," but stressed the problem was separate from the devastating ransomware attack that disrupted operations earlier this month.
A group of mostly Democratic House lawmakers pressed drugmaker AbbVie’s CEO on Tuesday over the increased prices of anti-inflammatory drug Humira and cancer drug Imbruvica in the U.S. in the years since they first became available.